Education
About Us
Working with TipRanks
Follow Us
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
RESEARCH TOOLSreports
Total Valuation
Firebrick Pharma Limited has a market cap or net worth of ―. The enterprise value is AU$13.92M.
Market Cap―
Enterprise ValueAU$13.92M
Share Statistics
Firebrick Pharma Limited has 227,321,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,321,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Firebrick Pharma Limited’s return on equity (ROE) is -0.56 and return on invested capital (ROIC) is -185.68%.
Return on Equity (ROE)-0.56
Return on Assets (ROA)-0.49
Return on Invested Capital (ROIC)-185.68%
Return on Capital Employed (ROCE)-1.86
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover<0.01
Inventory Turnover0.16
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio8.89
Price to Fair Value4.49
Price to FCF-7.43
Price to Operating Cash Flow-6.90
PEG Ratio-0.53
Income Statement
In the last 12 months, Firebrick Pharma Limited had revenue of 14.52K and earned -1.18M in profits. Earnings per share was -0.01.
Revenue14.52K
Gross Profit-22.78K
Operating Income-3.93M
Pretax Income-1.18M
Net Income-1.18M
EBITDA-1.08M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.93M and capital expenditures -66.49K, giving a free cash flow of -1.99M billion.
Operating Cash Flow-1.93M
Free Cash Flow-1.99M
Free Cash Flow per Share>-0.01
Dividends & Yields
Firebrick Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.75
52-Week Price Change20.00%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)43.16
Average Volume (3m)88.76K
Important Dates
Firebrick Pharma Limited upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Firebrick Pharma Limited as a current ratio of 7.19, with Debt / Equity ratio of 0.00%
Current Ratio7.19
Quick Ratio6.36
Debt to Market Cap0.00
Net Debt to EBITDA0.76
Interest Coverage Ratio-3.90K
Taxes
In the past 12 months, Firebrick Pharma Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Firebrick Pharma Limited EV to EBITDA ratio is -7.99, with an EV/FCF ratio of -3.69.
EV to Sales596.60
EV to EBITDA-7.99
EV to Free Cash Flow-3.69
EV to Operating Cash Flow-3.69
Balance Sheet
Firebrick Pharma Limited has AU$911.20K in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$911.20K billion.
Cash & Marketable SecuritiesAU$911.20K
Total DebtAU$0.00
Net Cash-AU$911.20K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per ShareAU$0.01
Margins
Gross margin is 91.68%, with operating margin of -27045.99%, and net profit margin of -8097.12%.
Gross Margin91.68%
Operating Margin-27045.99%
Pretax Margin-8097.12%
Net Profit Margin-8097.12%
EBITDA Margin-7469.32%
EBIT Margin-8090.19%
Analyst Forecast
The average price target for Firebrick Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast67.55%